Navigation Links
MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems
Date:3/20/2009

of every department and user.

"In four years, we've never had an instance where the system failed or where service was interrupted in anyway. MediTract's service is incredibly reliable and we've achieved our goal of centralizing key documents without placing much of a burden on the organization," Korbel said. "Setting up the system was easy and maintaining the database is just as easy."

Martin Memorial has also expanded its use of TractManager's products to include the company's PropertyTract solution, which manages facility related leases, service contracts, and property information for the health system's real estate and construction division.

"Martin Memorial has been an important client and we are very happy to hear of their many successes with our services. Our ability to assist them in improving efficiency and accountability in so many areas of their operation makes us incredibly proud," said Scott R. Jeffery, president and COO of MediTract. "Our contract management service and other compliance tools have been successful because they meet the needs of the nation's hospitals, and offer alternatives to hiring additional staff or dedicating existing staff member's valuable time to help manage contracts and compliance activities. Our customers are very confident that their compliance management efforts are performed as efficiently and effectively as possible when done with MediTract."

MediTract, Inc.

MediTract is the leading healthcare contract and document management provider, serving over 20 percent of the nation's hospitals. MediTract is a division of TractManager Inc., a national Internet-based technology firm specializing in secure, real-time access to customized and centralized contract and document management databases. MediTract was founded by healthcare executives and the company has an in-depth knowledge of how both providers and payers prioritize their physician,
'/>"/>

SOURCE MediTract
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
2. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
3. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
4. Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities
5. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
6. American Stock Exchange Accepts Encisions Plan to Regain Compliance
7. Sharps Compliance Corp. Announces First Quarter Fiscal Year 2008 Conference Call and Webcast
8. Critical HCCA Web/Audio Conference Will Review Office of Inspector General Compliance Concerns Outlined in FY 2008 Work Plan
9. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
10. Vendormate VISION 4.0(TM) Streamlines Healthcare Security and Compliance Efforts
11. Canada leads the way in contraceptive compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Tyco International Ltd. (NYSE: TYC ... Daniels for election to the Tyco Board of ... March 10, 2010. ,, Daniels, 55, is ... group of International Business Machines Corporation. In this ... Services business operations consisting of outsourcing services, integrated ...
(Date:12/16/2009)... Dec. 16 Medizone International, Inc. (OTC ... Board of Directors and the Board of Medizone ... Medizone International Inc. holds a 50% interest, agreed ... venture and reconvey to Medizone International all global ... Medizone International,s Chairman, Edwin G. Marshall said, "Time ...
(Date:12/16/2009)... myopia now than in the ,70s, study finds , , ... more common in the United States than it was ... study shows. , Researchers compared National Health and Nutrition ... from 1971 to 1972 and from 8,339 black and ... 12 to 54 years old. , The prevalence of ...
(Date:12/16/2009)... triathalons and appeared on The Amazing Race , , ... think of herself as part human, part machine. , A ... triathlete likes to describe herself. When she,s not training for ... auditoriums or posing nude with her metal leg crossed over ... ESPN Body Issue. , She is the first ...
(Date:12/16/2009)... Unisense FertiliTech A/S has received a further 1.6 million Euro ... EmbryoScope™ Embryo Monitoring System in order to meet the rapidly growing ... LD Pensions and Unisense A/S that continue to own each about ... ... December 16, 2009 -- Unisense FertiliTech A/S has received a further ...
Breaking Medicine News(10 mins):Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2
... FORCE BASE, May 24 When the space shuttle Atlantis ... Bicentennial Silver Dollars. This unique coin commemorates the birth ... the blind and is the first United States coin to ... be used to support the National Federation of the Blind ...
... sent to manufacturers by month,s end, CDC says , , ... reported progress towards a viable H1N1 swine flu vaccine ... Disease Control and Prevention saying they had two promising ... "Today CDC received, from one institution, a candidate vaccine ...
... injury takes practice, on and off the field, experts ... Just do it safely, says the American Academy of ... children aged 5 to 14 were treated for baseball-related ... medical settings, the U.S. Consumer Product Safety Commission notes. ...
... could be sent to manufacturers by month,s end, CDC ... viable H1N1 swine flu vaccine got a bit nearer ... promising candidate viruses for use in such a shot. ... vaccine virus," Dr. Anne Schuchat, the Centers for Disease ...
... founded by veteran attorney Bruce Abel, launches blog to help employers ... ... Los Angeles (Lexis Nexis) May 23, 2009 -- In an ... workers, rights and minimize the risk of employment litigation, Abel ...
... HAE:TSX- Loan of US$2.5 Million Expected to Close ... Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, ... Vancouver (NASDAQ: ANPI , TSX:ANP) are preparing ... loan from Angiotech to Haemacure in the amount ...
Other Medicine News:Health News:U.S. Closer to Viable Swine Flu Shot 2Health News:U.S. Closer to Viable Swine Flu Shot 3Health News:U.S. Closer to Viable Swine Flu Shot 4Health News:U.S. Closer to Viable Swine Flu Shot 5Health News:U.S. Closer to Viable Swine Flu Shot 6Health News:U.S. Closer to Viable Swine Flu Shot 7Health News:U.S. Closer to Viable Swine Flu Shot 8Health News:U.S. Closer to Viable Swine Flu Shot 9Health News:U.S. Closer to Viable Swine Flu Shot 10Health News:U.S. Closer to Viable Swine Flu Shot 11Health News:U.S. Closer to Viable Swine Flu Shot 12Health News:U.S. Closer to Viable Swine Flu Shot 13Health News:For Young Ballplayers, Support and Caution Are Key 2Health News:U.S. Progressing on Swine Flu Vaccine 2Health News:U.S. Progressing on Swine Flu Vaccine 3Health News:U.S. Progressing on Swine Flu Vaccine 4Health News:U.S. Progressing on Swine Flu Vaccine 5Health News:U.S. Progressing on Swine Flu Vaccine 6Health News:U.S. Progressing on Swine Flu Vaccine 7Health News:U.S. Progressing on Swine Flu Vaccine 8Health News:U.S. Progressing on Swine Flu Vaccine 9Health News:U.S. Progressing on Swine Flu Vaccine 10Health News:U.S. Progressing on Swine Flu Vaccine 11Health News:U.S. Progressing on Swine Flu Vaccine 12Health News:U.S. Progressing on Swine Flu Vaccine 13Health News:Abel Law Offices Introduces Free Web Resource for California Employers Navigating Workplace Laws 2Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 2Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 3Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 4Health News:Haemacure Update on Proposed Collaboration and Bridge Financing 5
(Date:12/16/2009)... 16 The Boards of Silence Therapeutics ... to announce the merger of their businesses to ... RNAi (RNA interference). The enlarged company, to ... discovery, development and delivery technologies, a broad internal ... of intellectual property. ,, The Directors believe ...
(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... 3 registration clinical trial for KRX-0401 (perifosine), ... / refractory multiple myeloma patients. ,, The ... to Assess the Efficacy and Safety of ... (Velcade®) and Dexamethasone in Multiple Myeloma Patients ...
(Date:12/16/2009)... 16 , ... Daniel,Tome,s Supervision and Published* in November 2009, in ... Society "Bone", Reveal new Benefits for,Peptan(TM) in Osteoporosis ... to consumer concerns regarding long-term bone health,Rousselot has ... to demonstrate,that an oral intake of Peptan(TM) may ...
Breaking Medicine Technology:Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7Published in "Bone" Journal, Scientific Researches Confirm Peptan(TM) Hydrolyzed Collagen Benefits on Bone Health 2GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 1GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 2Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 1Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 1Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 3Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 4
... 2007 /PRNewswire-FirstCall/ --,CuraGen Corporation announced today that ... deacetylase (HDAC) inhibitor being,investigated for the treatment ... for the prevention of severe oral mucositis,will ... for Cancer,Research (AACR) 2007 Annual Meeting in ...
... April 11, 2007 /PRNewswire-FirstCall/ --,Advanced Magnetics today ... clinical trials of ferumoxytol as an,intravenous (IV) ... at approximately 6:00 pm EDT as posters ... in Orlando,Florida. These posters are available in ...
Other Medicine Technology:CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 2CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 3CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8
... With the increase in Endoscopic cases it is ... Monitor with the Surgical Light. This combination ... without having to adopt an uncomfortable pose. ... including the NUVO Monitoring System. As such ...
... This configuration offers all the performance of a ... perfectly for use in Outpatient Settings, Minor Procedure ... Mounting two single lights either side of the ... in a General OR when combining Flat Screen ...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....
Medicine Products: